Health Care : Current Reviews

Challenges and opportunities for the developmental drug trials and health outcomes in the UAE

4^th Global Summit on Healthcare

November 09-10, 2015 Dubai, UAE

Satish Chandrasekhar Nair

Tawam Hospital, UAE

Posters-Accepted Abstracts: Health Care: Current Reviews

Abstract:

Recent reports indicate that up to 31% of the world�??s clinical trials are currently being conducted outside of the US and 25% of the investigational new drug applications include data from clinical trials conducted at international study sites. The need for diverse patient population for research, decreased trial costs, improved subject accrual and access to rare diseases is additional driving forces for the expansion of international clinical research. The high population growth, demand for medication, improved life expectancy, increased prevalence of life-style related disease and access to rare diseases in the ME and North Africa countries should drive the conduct of clinical trials in these countries; yet the region hosts only about 0.5% of global clinical trial sites. Regulatory challenges and oversight issues can be overcome through strategic planning by the local CRO. Risk-based monitoring and education and cross training of healthcare professionals in the region can overcome barriers related to trial quality and subject protection. Population characteristics, growing healthcare infrastructure, and the state-of-the-art communication technologies provide clear advantages for clinical trial subject recruitment in the region. Low physician salaries, lower operating costs and the expected increase in pharmaceutical sales in the region are significant incentives for the future conduct of clinical trials. Faster recruitment pace, reduced clinical trial development costs and healthy global pharmaceutical sales forecast, further make this region attractive for the future conduct of clinical research.

Biography :

Email: schandra@tawamhospital.ae